SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-011851
Filing Date
2019-08-08
Accepted
2019-08-08 12:00:26
Documents
46
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 497178
2 ex31-1.htm EX-31.1 18692
3 ex31-2.htm EX-31.2 18748
4 ex32.htm EX-32 8068
  Complete submission text file 0001493152-19-011851.txt   2061005

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pvct-20190630.xml EX-101.INS 247299
6 XBRL SCHEMA FILE pvct-20190630.xsd EX-101.SCH 29339
7 XBRL CALCULATION FILE pvct-20190630_cal.xml EX-101.CAL 36223
8 XBRL DEFINITION FILE pvct-20190630_def.xml EX-101.DEF 85052
9 XBRL LABEL FILE pvct-20190630_lab.xml EX-101.LAB 190469
10 XBRL PRESENTATION FILE pvct-20190630_pre.xml EX-101.PRE 140492
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 191008377
SIC: 2834 Pharmaceutical Preparations